Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
This Wednesday, several analysts are adjusting their price targets on French and European stocks, with revisions particularly in energy, banking, and advertisin…
As of 10:00 AM this Wednesday, March 18, 2026, the CAC 40 stands at 8026.88 points, up by 0.66%. The opening session sees 28 stocks rising against 12 declining,…
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, an experimental oral glucosylceramide synthase inhibitor…
Technip Energies has signed an agreement to acquire a minority stake in the DEZiR project, a synthetic aviation fuel plant located in Rouen. This investment is …
Arnaud Bolloré's holding company reports a net cash position of 5.1 billion euros and increases its dividend by 9% to 4.80 euros per share. However, this financ…
AerCap Holdings N.V. has signed a firm order with Airbus for 100 A320neo family aircraft, including 23 A320neos and 77 A321neos.
Vallourec has won a contract with BP Berau Ltd. for the supply of premium pipes and VAM® connections for the Tangguh project, the first offshore Carbon Capture …
The French animal health specialist released its 2025 results on Wednesday. Virbac reported a solid organic growth of 7.9% and maintained an operating margin of…
The French vaccine laboratory recorded an operational loss of €82.1 million in 2025, despite a 3% increase in revenue to €174.7 million. This contradiction high…
This Wednesday, five listed companies are publishing their results, including four annual reports and one semi-annual review. Here's an overview of the stocks t…
Mexedia S.p.A., an Italian technology company listed on Euronext Growth Paris, had its Extraordinary General Meeting on March 13, 2026, approve a set of statuto…
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
